LifeLabs is a Canadian-owned healthcare company that has been in business for over 50 years. LifeLabs has a national collection network that streamlines specimen procurement and sample submission, simplifying the testing process for both healthcare provider and patient.
LifeLabs hereditary cancer panel offers a pan-cancer screening approach that includes full sequencing and copy number variant analyses of 84 of the more common genes associated with increased risk of developing hereditary breast, ovarian, uterine, colorectal, gastric, prostate, melanoma, and pancreatic cancer. Pre- and post-test genetic counselling is included in the testing.
The cost of the test will either be $600 or $950 (Canadian dollars), depending on the panel selected
Genetic testing for various cancers, such as breast, colon and prostate.